Inovio shares tumble as analysts say COVID-19 vaccine update left more questions than answers – MarketWatch

Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the business reported a wider-than-expected second-quarter loss and offered a minimal upgrade on its COVID-19 vaccine candidate which … [+5016 chars]